Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWAND.L Regulatory News (WAND)

  • There is currently no data for WAND

Block Listing Interim Return

1 Jul 2016 07:01

RNS Number : 9008C
WANdisco Plc
01 July 2016
 

BLOCK LISTING INTERIM RETURN

 

 

Date: 1 July 2016

 

Name of issuer:

WANdisco plc

Name of scheme(s):

i. WANdisco plc UK Enterprise Management Incentive Plan 2012

ii. WANdisco plc UK Unapproved Sub-Plan 2012

iii. WANdisco plc US Sub-Plan 2012

iv. WANdisco plc Long Term Incentive Plan 2013

v. WANdisco plc US Equity Incentive Plan 2013

vi. WANdisco plc UK EMI Sub-plan 2013

Period of return:

From: 1 January 2016 To: 30 June 2016

Balance of unallotted securities under scheme(s) from previous return:

Ordinary shares of 10p each as follows:

i. 506,934

ii. 344,760

iii. 535,765

iv. 0

v. 0

vi. 0

Plus: The amount by which the block scheme(s) has been increased since the last return:

 

i. 0

ii. 0

iii. 0

iv. 3,000,000

v. 200,000

vi. 500,000

Less: Number of securities issued under the scheme(s) during the period:

 

i. 27,500

ii. 0

iii. 0

iv. 380,639

v. 0

vi. 0

Equals: Balance under the scheme(s) of securities not yet issued at the end of the period:

 

i. 479,434

ii. 344,760

iii. 535,765

iv. 2,619,361

v. 200,000

vi. 500,000

Contact name and telephone:

Louise Hall, 0114 303 9985

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BLRFMMBTMBBJTAF
Date   Source Headline
4th Oct 20237:00 amRNSWANdisco plc rebrands as Cirata plc
22nd Sep 20236:24 pmRNSHolding(s) in Company
11th Sep 20237:00 amRNSInterim results
7th Sep 20233:30 pmRNSNotice of Results
30th Aug 20236:04 pmRNSResult of Annual General Meeting
18th Aug 20236:05 pmRNSBlock Admission Notification
16th Aug 20238:07 amRNSGM Signs Multi-Project Contract with WANdisco
31st Jul 20237:00 amRNSHolding(s) in Company
28th Jul 20233:25 pmRNSHolding(s) in Company
26th Jul 20237:00 amRNSBoard Changes
25th Jul 20237:30 amRNSRestoration - WANdisco plc
25th Jul 20237:00 amRNSConfirmation of Exchange Rate
24th Jul 202310:45 amRNSResult of GM
17th Jul 20235:00 pmRNSPosting of Annual Report and Accounts
12th Jul 20231:45 pmRNSPublication of Annual Report and Accounts
11th Jul 20237:00 amRNSContract Win
10th Jul 20237:00 amRNSContract Renewal
7th Jul 20237:00 amRNSConfirmation of Fundraise
5th Jul 20236:29 pmRNSPublication of Notice of General Meeting
5th Jul 202311:30 amRNSUpdate to Fundraise Timetable
4th Jul 20237:00 amRNSResult of Fundraising
3rd Jul 202312:00 pmRNSLaunch of Fundraise
29th Jun 20237:00 amRNSPreliminary Unaudited Results FY22
28th Jun 202311:51 amRNSUpdate on Timing of Results and Equity Issue
26th Jun 20233:30 pmRNSTurnaround Plan Momentum
26th Jun 20237:00 amRNSWANdisco Signs New Agreement with Accenture
15th Jun 20239:46 amRNSFCA investigation timeline update
9th Jun 20237:00 amRNSSuccessful Shareholder General Meeting Next Steps
6th Jun 20233:49 pmRNSResult of General Meeting
19th May 20236:22 pmRNSPublication of Circular and Notice of GM
19th May 20236:04 pmRNSBoard Change
15th May 20237:00 amRNSExploring Funding Options
9th May 20235:30 pmRNSWANdisco
9th May 20237:00 amRNSAppointment of Interim Chief Executive
4th May 20237:00 amRNSOrganisation Update
28th Apr 20237:00 amRNSIndependent Investigation Update
20th Apr 20237:00 amRNSFCA Investigation
5th Apr 20237:00 amRNSExecutive Chair Appointment Confirmation
4th Apr 20237:00 amRNSContract Renewals
3rd Apr 20237:00 amRNSBoard Change and Investigation Update
22nd Mar 20237:00 amRNSAppointment of Interim Chair
10th Mar 20239:31 amRNSIndependent Investigation Appointment
9th Mar 20237:30 amRNSSuspension - WANdisco plc
9th Mar 20237:00 amRNSTrading Revision
7th Mar 20237:00 amRNSAppointment of Joint Broker
6th Mar 20237:00 amRNSResponse to press speculation
1st Mar 20238:16 amRNSTotal Voting Rights
1st Feb 20234:05 pmRNSTotal Voting Rights
24th Jan 20237:00 amRNS$9m industrial and consumer goods contract win
11th Jan 20237:00 amRNSFY22 Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.